The extent and progression of exposure to feline infectious peritonitis (FIP) virus in the cheetah, Acinonyx jubatus, was monitored by a world-wide serological survey with indirect fluorescent antibody titers to coronavirus. The indirect fluorescent antibody assay was validated by Western blots, which showed that all indirect fluorescent antibody-positive cheetah sera detected both domestic cat and cheetah coronavirus structural proteins. There was a poor correlation between indirect fluorescent antibody results and the presence of coronaviruslike particles in cheetah feces, suggesting that electron microscopic detection of shed particles may not be an easily interpreted diagnostic parameter for FIP disease. Low, but verifiable (by Western blots [immunoblots] ) antibody titers against coronavirus were detected in eight free-ranging cheetahs from east Africa as well as from captive cheetahs throughout the world. Of 20 North American cheetah facilities screened, 9 had cheetahs with measurable antibodies to feline coronavirus. Five facilities showed patterns of an ongoing epizootic. Retrospective FIP virus titers of an FIP outbreak in a cheetah-breeding facility in Oregon were monitored over a 5-year period and are interpreted here in terms of clinical disease progression. During that outbreak the morbidity was over 90% and the mortality was 60%, far greater than any previously reported epizootic of FIP in any cat species. Age of infection was a significant risk factor in this epizootic, with infants (less than 3 months old) displaying signfficantly higher risk for mortality than subadults or adults. Based upon these observations, empirical generalizations are drawn which address epidemiologic concerns for cheetahs in the context of this lethal infectious agent.
Feline infectious peritonitis (FIP) is a fatal immune-mediated disease of domestic cats that is a consequence of infection by an immunogenic coronavirus, FIP virus (FIPV), with a positive-stranded RNA genome. The epizootiology and etiology of FIP are not well understood, despite considerable study since the original description in 1963 (3, 10, 15, 37, 38) . At least three clinical forms of disease are recognized: (i) effusive or wet FIP, which is characterized by fibrinous peritonitis or pleuritis and which is always fatal; (ii) the noneffusive or dry form of FIP, which does not have the fluid but which does have the fibrinous peritoneal deposition and is also fatal; and (iii) a subclinical enteritis, which is mild in terms of recognizable symptoms (27; J. E. Barlough and C. A. Stoddart, in C. E. Greene, ed., Infectious Diseases of the Dog and Cat, in press). In domestic cats the fatal form is rare (ca. 1% of an infected colony will die), and the virus seldom affects more than 10% of domestic cats in a group even under the most severe conditions for disease (27) . Several FIPV isolates have been described, and they may vary from extreme virulence and pathology to subclinical outcomes (5, 21, 27, 28 (2, 6, 9, 31) . What initially appeared as an acute anorexia, jaundice, and enteritis in an adult cheetah resulted in death from FIP and rapid viral transmission to other resident cheetahs. Within 6 months, every cheetah in the facility developed immunofluorescent antibodies to feline coronavirus, ostensibly because of exposure to the fatal FIPV that had afflicted the original cheetah (2, 9, 23) . Over the next 12 months, clinical signs (intermittent and chronic diarrhea, chronic gingivitis, hepatic and renal disease, weight loss, and depression) and morbidity were apparent in over 90% of the cheetahs. Despite aggressive clinical therapy, a total of 27 cheetahs died between 1983 and 1987 from one or more of the following coronavirus-associated diseases: fibrinous peritonitis, renal and hepatic disease, enteritis and malabsorption syndrome, hemorrhagic gastroenteritis, and FIP-associated kitten mortality complex. In the same period, 18 cheetahs were exposed to the FIPV and survived, thereby permitting an overall mortality estimate of 60%. Since the Oregon epizootic, and perhaps in some part because of it, the understanding of the etiology of FIP in cheetahs has become an important priority in discussions of captive breeding and wildlife management strategies for the species (8, 19 An important risk factor that would influence mortality due to FIPV appears to be age at exposure (see reference 18 for dates of birth). Of the 45 cheetahs studied, 20 were exposed as infants (less than 5 months old); of these, only 3 (15%) survived. The survival rate of 25 older cheetahs was 60%. The overall mortality related to FIPV exposure was 60%. The relative survival of infants exposed to FIPV was significantly different from that for all cheetahs (X2 = 9.37; P < 0.01).
Among the cheetahs which succumbed to FIP, the median time from seroconversion to death was 7 to 12 months (Fig.  2) . Three animals, SB258, SB259, and SB294, each survived over 38 months before dying of FIP, but their FIPV antibody titer patterns are perhaps illuminating. All three cheetahs showed declining antibody titers in 1983 through 1984 (the titer of SB259 dropped to c25 for two consecutive samples in 1984), and thereafter the two tested animals developed elevated titers in 1985 until their deaths in 1986 (Fig. la) . Since the three animals were housed in the same pens, their parallel pattern may indicate an acute secondary infection or possibly a common environmental change that caused activation of latent FIPV. The other surviving cheetahs have lived for up to 5 years (Fig. 2b) without apparent symptoms.
Seroprevalence in captive and free-ranging cheetah populations. Coronavirus antibody titers from 101 cheetah serum samples collected from four locations outside of the United States are presented in Table 1 . With the exceptions of sera collected in the Serengeti from 25 free-ranging cheetahs (25) , the sera were from captive animals, although several of these cheetahs in Africa were born in the wild. Low antibody titers were detected in a few animals from each locale, but only two cheetahs (one from the Serengeti and one captive animal in Kenya) had titers of 1:100 or greater. Low IFA titers (1:25) were verified by Western blots (see below). With the exception of these infrequent low titers, the overall titer pattern in each of these locations resembles the Oregon situation before 1982 (Table 1 ).
In the United States, the Oregon epizootic influenced the cheetah species survival plan, organized by the American Association of Zoological Parks and Aquariums, to recommend periodic monitoring of captive cheetahs for coronavirus titers. The distribution of feline coronavirus titers in serum samples from 132 cheetahs held in 20 North American facilities (zoos and wildlife reserves) is presented in Table 2 .
Eight of the facilities provided samples of their colonies in both 1986 and 1987 (1 through 8 in Table 2 ). Among these facilities, there were two patterns that emerged: (i) those in which all cheetahs were clearly seronegative over time (facilities 1 through 4); and (ii) those in which cheetahs were clearly seropositive in 1986 (facilities 5 through 8), with a progression from low titers in a few animals to higher titers in more animals. Like the experience at Wildlife Safari, the FIPV appears to spread to other cheetahs in these facilities and to proceed with increasing coronavirus titers. Interestingly, animals in these four facilities did not exhibit clinical symptoms of FIP, although FIP pathology has been observed in two other North American facilities not monitored serologically in our studies (19) as well as in two sites in Europe and three facilities in Japan (Marker-Kraus et al., manuscript in preparation). The remaining surveyed institutions only produced one-time samples, so the results were less easily interpreted. However, cheetahs in facilities 9 through 15 produced low or no titers, similar to those from DeWildt and Whipsnade, whereas facilities 16 through 20 maintained cheetahs with higher titers more reminiscent of those at Wildlife Safari in the years after the FIP outbreak.
IFA titers do not correlate with EM screens for coronaviruslike particles. Seventy-four fecal samples were submitted from captive cheetah populations at 13 facilities in North America for EM analysis. The overall prevalence of cheetahs with evidence of fecal coronaviruslike particles was 31% (21 of 68) ( Table 2 ). Of the 21 cheetahs shedding coronaviruslike particles in their feces, only 8 (38%) had demonstrable serum IFA titers to coronavirus. The high frequency of discordance between feline coronavirus antibodies and the presence of fecal particles is difficult to explain but could be the result of the occurrence of coronaviruslike particles in the feces which are immunologically distinct from the pathological FIPV. Virus isolation was attempted by using CrFK cells on all fecal samples in which particles were observed. None of these attempts, however, was successful. system, and the presence of exogenous protease to enhance viral replication (5) (6) (7) 20) .
Western blot analyses. Serum samples (diluted 1:5, 1:10, 1:50, and 1:100) from 93 African cheetahs (Table 3) plus from 15 cheetahs from Wildlife Safari were screened by using Western blots against four feline coronavirus strains (Fig. 3) . All IFA-positive animals, except one with a titer of 1:100, detected coronavirus proteins of each FIPV isolate on Western blots. The blot profile varied for each isolate, most appreciably in the membrane (or matrix) protein region, where a common 29-kilodalton band was detected in strains FIPV WSU 79-1146, FIPV Nor-15, and FECV WSU 79-1683 but was faint or absent in the FIPV UCD-1 preparation. The intensity of staining of each band was a function of antibody titer, but there were also some noticeable differences and similarities between individuals on different continents. For example, the isolate from an East African cheetah (AJU 220) showed a major 29-kilodalton band like that of the Nor-15 strain and had the same Western blot profile as the isolate from one captive North American cheetah (AJU 87) but differed from the isolate from another East African cheetah (AJU 219) which failed to show the 29-kilodalton protein (Fig. 3) . The numbers of African cheetah serum samples that detected antigens of the four isolates of domestic cat coronavirus are presented in Table 3 . This table demonstrates the highly conserved antigenic nature of the nucleoprotein that was identified in most IFA-positive cheetah sera with all domestic cat coronaviruses in this study. Less conserved were the membrane antigens, which were recognized by 20 to 85% of the serum samples, depending upon the virus isolate. These data suggest that African cheetahs have been exposed to several immunologically different strains of coronaviruses.
Comparison of cheetah coronavirus isolate to domestic cat coronaviruses. A feline coronavirus was isolated from a cheetah from Oregon which perished from FIP (7). The specificity of serum samples from several IFA-positive domestic cats and cheetahs were tested by Western blotting for reactivity to the cheetah isolate designated AJUCV-1 (8) . Both the cheetah and domestic cat sera detected nucleocapsid proteins of AJUCV-1, FIPV 79-1146, and FIPV UCD-1 (Fig. 4) . Reactivity of the sera from both species to the membrane protein was variable, indicating antigenic heterogeneity within the viral populations that infect these animals.
DISCUSSION
We have presented a serological survey of the incidence and pattern of exposure to feline coronavirus in captive and free-ranging cheetahs in North America, Europe, and Africa. In addition we have summarized the results of a retrospective serum survey of the FIP epizootic that began in 1982 at a cheetah-breeding facility in Winston, Oreg. Because of the shortage of epidemiological studies of this disease in cheetahs and in light of the danger of too-strict extrapolation from disease progression in the domestic cat, it seems important to understand the lessons of this epizootic as a basis for interpreting incipient outbreaks in cheetah populations in captivity and in their natural range.
The Oregon outbreak occurred with the arrival at the facility in 1982 of an infected animal from another park. Before 1982 all of the cheetahs in the park were coronavirus seronegative. Within 8 months all cheetahs in the park seroconverted, and after 4 years 60% had died of FIP-related disease. Age of infection was a significant risk factor, with infants (0 to 5 months of age) being at greater risk. The median time from seroconversion (as a marker of exposure) (Table 3) . Nevertheless, despite the isolation of clinically distinct domestic cat coronaviruses, it has not been possible to develop typespecific immunological reagents that discriminate between them (11) (12) (13) (14) . There is currently no direct evidence for functional heterogeneity of cheetah coronaviruses; however, the discordance of coronaviruslike particles detected by EM and the results of IFA and Western blot analyses (Table 2) is consistent with appreciable antigenic diversity among cheetah coronaviruses. Second, there could be genetic differences in the host cheetahs that influence the pathology. This is possible despite our earlier observation of the reduced genetic diversity of cheetahs (23-26), since those results showed reduced (10 to 100-fold) diversity but not complete homozygosity at all loci. In fact, we have observed limited heterozygosity in cheetahs by using molecular clones of one gene involved in immune surveillance, the major histocompatibility complex (40a (27) or with feline immunodeficiency virus (40) .
In hopes of resolving some of these possibilities, we have used three different methods for detecting feline coronavirus in cheetahs: IFA assay, Western blots, and EM screening for coronaviruslike particles in feces. The IFA method seems rather verifiable with clinical disease, based upon the Oregon epizootic and disease outbreaks in several other facilities possible that this discordance would result from an acquired infection before the development of an immune response. Based upon the well-known existence of antigenic drift in RNA viruses (41) and in coronaviruses (4, 17, 32, 39) , it is also likely that these particles may represent viruses that are morphologically similar to but antigenically distinct from the recognized strains of FIPV and FECV (20, 36) . The discordance between IFA serology results versus EM coronavirus screening in cheetahs makes it difficult to interpret the EM results as a diagnostic parameter for cheetahs.
The observations of the Oregon outbreak plus the results of the IFA serum survey for free-ranging and captive cheetahs have suggested the following conclusions, which we recommend for consideration of this pathogen in managed cheetah populations.
(i) Pathological FIPV is highly infectious and spreads rapidly among cheetahs when physical contact occurs, probably through exchange of excretory material and/or secretions (34) .
(ii) Pathological FIP is a dynamic disease process that is correlated with continuous, measurable, and often increasing titers to feline coronavirus.
(iii) Occasional low antibody titers have been observed in several populations, including free-ranging animals (Table 1 and 2), which could signal an incipient disease epizootic but may also reflect infection with a nonpathological but antigenically related coronavirus. The confirmation of a clinical epizootic would require time points showing increasing numbers and higher titers (as in facilities 5 through 8) plus morbidity. Facilities with increasing titers but no disease (facilities 5 through 8 in Table 2 ) may prove particularly interesting, because they raise the possibility of clinical heterogeneity of virus isolates between different facilities. Long-term monitoring of these facilities to confirm this hypothesis is desirable.
The present results indicate that coronavirus infections are occurring in captive and free-ranging cheetah populations, as has been reported for domestic cats (1, 16, 27) . The factors that appear to be important with the occurrence of FIP in a population of cats are a combination of a virulent strain of virus together with a susceptible group of cats (1, 16, 27) . The cheetah has been reported as being unusually vulnerable to FIPV, based on epizootics that have occurred in the United States, Canada, Ireland, Namibia-Southwest Africa, The Netherlands, and Japan (9, 18, 19, 23) . The results of the study reported herein indicated that the exposure rate to feline coronavirus, or a closely related coronavirus, is similar to that reported for domestic cats. Until further information is reported concerning coronavirus infections in exotic cats, the management of cheetahs should follow basic guidelines for control of infectious diseases, such as segregation of seropositive animals from seronegative animals, quarantine before and after arrival at the zoologic facility, and regular monitoring by serology (8) .
